Innovations in Cancer Treatment and Predictive Modeling Capture 2018 Wells and Kuzneski Competitions

Posted by & filed under Uncategorized .

A year ago the Food and Drug Administration (FDA) approved the first gene therapy in the U.S. The drug, Kymyriah, from pharmaceutical company Novartis, is a type of immunotherapy called chimeric antigen receptor (CAR) T cell therapy. It was approved to treat acute lymphoblastic leukemia, a cancer of the blood. It works by drawing blood… Read more »

Long-Time Pitt Collaborators Forge Path to Impact for Discovery

Posted by & filed under Uncategorized, News .

Pictured from left, Dr. Alan Wells, Dr. Cecelia Yates and Sean McDonald, CEO of Ocugenix Inc., which is developing technology created by Drs. Wells, Yates and Dr. Ian Connor to treat eye diseases. Pitt-licensed technology provides new hope for wet-AMD treatment   By Mike Yeomans When setting out to commercialize an early-stage healthcare discovery, the… Read more »